| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Powl Brian T. | Chief Commercial Officer | C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO | Thomas Doyle, Attorney-in-fact for Brian Powl | 29 Sep 2025 | 0001934232 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KURA | Common Stock | Award | $0 | +48,900 | +82% | $0.000000 | 108,567 | 27 Sep 2025 | Direct | |
| transaction | KURA | Common Stock | Sale | $79,505 | -8,891 | -8.2% | $8.94 | 99,676 | 29 Sep 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25. |